Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long ...

Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing ...

An estimated 6.9 million Americans age 65 and older are living with Alzheimer's dementia today, according to the National ...

“Our discovery of RORB for these selectively vulnerable cells gives us the opportunity to study in detail exactly why they ...

Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

When Dennis Carr learned he had early Alzheimer’s disease, he immediately thought of his older brother who had died of the ...

The findings suggest that symptoms of Alzheimer's are closely linked to the makeup of the gut. Today, evidence strongly ...

Eli Lilly's Kisunla (donanemab) has been approved in Japan for early symptomatic Alzheimer's, including mild cognitive ...

This past weekend was the annual Walk to End Alzheimer’s in Eagle. Every year, the event is gaining in attendance. We all are ...

Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...

Japan, with its rapidly aging population, is expected to have more than 5 million patients with dementia by 2030. Alzheimer’s ...

Flowers decorated with names of loved ones spun in the wind, children ran around filling the sidewalks with affirming ...